Australia's largest stock trading and investment forum Australia's #1 stock forum

ACW

4.00%

2.6¢ actinogen medical limited

Indications and collaborations, page-57

First 57 Last

Share
Profile

Follow
Tragore

611 Posts.

280

07/02/19

09:58

Post #: 37358901
Share

Originally posted by Gycor: ↑

I have options and I need to see more strength before I convert.
I have always said that it is a binary outcome even though they have money for future trials for other brain related complaints.
I might convert and then sell half of all my shares... that way I cant punish myself and say I lost everything or I had a great ride with what I had left.
It really is a toss of a coin and people need to come to terms with this. Don't think otherwise because its all about the ability to transfer the medication into the brain (breaking down the barrier and having a direct interface with the brain).

I recently had a friend who died of a tumour on the brain. Chemo removed all the tumour in the rest of his body but because the last tumour was in the brain the chemo did not get to kill this one because of the transference issue.

Break this and you will see $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ LIKE YOU WILL NOT BELIEVE
but if not the SP will be dumped.

Its a hard ride to accept but it is reality and we need to come to terms with this.

Placebos may have been reported by the WA news.... who knows....

Not long now.

Are you in it now for an adrenalin rush?????

Expand

From the company presentation, they previously confirmed the drug does successfully cross the brain barrier. https://www.asx.com.au/asxpdf/20181126/pdf/440mhy4rhpvp2p.pdf page 11.

ACW Price at posting: 5.8¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 22 more messages in this thread...

First 57 Last

Add ACW (ASX) to my watchlist

(20min delay)
Last 2.6¢		Change 0.001(4.00%)		Mkt cap ! $76.57M

Open	High	Low	Value	Volume
2.5¢	2.7¢	2.5¢	$192.6K	7.531M

Buyers (Bids)

No.	Vol.	Price($)
15	4201185	2.5¢

Sellers (Offers)

Price($)	Vol.	No.
2.6¢	8694	1

View Market Depth

No.	Vol.	Price($)
13	4113185	0.025
23	6288803	0.024
25	5822139	0.023
14	8036010	0.022
18	2756880	0.021

Price($)	Vol.	No.
0.027	4207443	6
0.028	1031405	4
0.029	4642413	8
0.030	2614680	7
0.031	751771	3

Last trade - 16.10pm 04/10/2024 (20 minute delay)

ACW (ASX) Chart

Indications and collaborations, page-57

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Indications and collaborations, page-57

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News